Q&A: BC Cancer Agency's Robert Holt on Sequencing the Immune Repertoire

In Sequence spoke with Holt about how new sequencing technologies will soon be able to provide new insights into immunology.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.